Recruiting

Observational Study

Sponsor:

Shirley Ryan AbilityLab

Code:

NCT06516458

Conditions

Multiple Sclerosis

Multiple Sclerosis, Secondary Progressive

Multiple Sclerosis Relapse

Multiple Sclerosis, Relapsing-Remitting

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Camera Based Kinematic Analysis

Study Details

Brief summary:

The purpose of this study is to develop a measurement of walking quality, called Gait Deviation Index (GDI) for people with Multiple Sclerosis (MS).

Conditions

Multiple Sclerosis

Multiple Sclerosis, Secondary Progressive

Multiple Sclerosis Relapse

Multiple Sclerosis, Relapsing-Remitting

Study ID

NCT06516458

Start date

Jul, 2024

Status verified date

Jul, 2024

Completion date

Jul, 2026

Anticipated

Primary completion date

Jul, 2025

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion criteria:

  • Diagnosis of relapsing form of MS (including relapsing-remitting MS and secondary progressive MS)
  • Able to ambulate overground
  • Relapse free for at least 1 month
  • Age ≥18 and ≤ 75 years
  • Participants using dalfampridine will be eligible if taking the same daily dose for at least 2 months prior to screening

Exclusion criteria:

- Orthopedic injuries, fractures, surgeries or other conditions affecting locomotor function or weight bearing

Study Design

Enrollment

40 participants

Anticipated

Interventions and Outcome Measures

Arms

Observation

Gait quality observation

Interventions

Camera Based Kinematic Analysis

Observational Study using Camera Based, Marker Less Kinematic Analysis of gait quality of persons with Multiple Sclerosis

Primary outcome measure

  • Kinematics of the gait cycle [ Time Frame: at the time of session ]

Central Contacts and Locations

Locations

Shirley Ryan AbilityLab

Recruiting

Chicago, Illinois, United States, 60611

Contacts

More Information

Sponsor

Shirley Ryan AbilityLab

Last update posted

Jul 24, 2024

Last verified

Jul, 2024

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Shirley Ryan AbilityLab on 2024-07-24.